Related Experiment Video
Updated: May 7, 2026

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
17β-Estradiol alters oxidative stress response protein expression and oxidative damage in the uterus
Lisi Yuan1, Alicia K Dietrich1, Ann M Nardulli1
1Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.
Abstract:
The steroid hormone 17β-estradiol (E2) has profound effects on the uterus. However, with the E2-induced increase in uterine cell proliferation and metabolism comes increased production of reactive oxygen species (ROS). We examined the expression of an interactive network of oxidative stress response proteins including thioredoxin (Trx), Cu/Zn superoxide dismutase (SOD1), apurinic endonuclease (Ape1), and protein disulfide isomerase (PDI). We demonstrated that treatment of ovariectomized C57BL/6J female mice with E2 increased the mRNA and protein levels of Trx, but decreased SOD1 and Ape1 mRNA and protein expression. In contrast, E2 treatment increased PDI protein levels but had no effect on PDI transcript levels. Interestingly, E2 treatment also increased two markers of cellular damage, lipid peroxidation and protein carbonylation. Our studies suggest that the decreased expression of SOD1 and Ape1 caused by E2 treatment may in the long term result in disruption of ROS regulation and play a role in endometrial carcinogenesis.
Insights
17β-estradiol (E2) alters uterine oxidative stress response proteins. E2 increases thioredoxin but decreases SOD1 and Ape1, potentially disrupting reactive oxygen species (ROS) regulation and contributing to endometrial cancer.
Area of Science:
- Reproductive Endocrinology
- Molecular Biology
- Oxidative Stress Research
Background:
- The steroid hormone 17β-estradiol (E2) significantly impacts uterine function, promoting cell proliferation and metabolism.
- Increased cellular activity driven by E2 leads to elevated production of reactive oxygen species (ROS), a key component of oxidative stress.
- Understanding the balance of oxidative stress response proteins is crucial for comprehending uterine health and disease.
Purpose of the Study:
- To investigate the effect of E2 on the expression of key oxidative stress response proteins in the uterus.
- To determine how E2 influences the mRNA and protein levels of thioredoxin (Trx), Cu/Zn superoxide dismutase (SOD1), apurinic endonuclease (Ape1), and protein disulfide isomerase (PDI).
- To explore the potential long-term consequences of E2-induced oxidative stress changes on endometrial health and carcinogenesis.
Main Methods:
- Ovariectomized C57BL/6J female mice were treated with E2.
- Quantitative real-time PCR was used to measure mRNA expression levels of target proteins.
- Western blotting was employed to assess protein expression levels.
- Markers of cellular damage, including lipid peroxidation and protein carbonylation, were quantified.
Main Results:
- E2 treatment significantly increased both mRNA and protein levels of thioredoxin (Trx).
- Conversely, E2 administration led to decreased mRNA and protein expression of SOD1 and Ape1.
- While PDI protein levels were elevated by E2, its transcript levels remained unaffected.
- Significant increases in lipid peroxidation and protein carbonylation were observed following E2 treatment.
Conclusions:
- E2 exerts differential effects on the expression of key oxidative stress-related proteins in the uterus.
- The downregulation of SOD1 and Ape1 by E2 may impair the uterus's ability to regulate ROS effectively.
- These findings suggest a potential role for E2-mediated disruption of oxidative stress balance in the development of endometrial carcinogenesis.
More Related Videos
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Oogenesis
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

